Categories
- Global News Feed
- Uncategorized
- Alabama Stem Cells
- Alaska Stem Cells
- Arkansas Stem Cells
- Arizona Stem Cells
- California Stem Cells
- Colorado Stem Cells
- Connecticut Stem Cells
- Delaware Stem Cells
- Florida Stem Cells
- Georgia Stem Cells
- Hawaii Stem Cells
- Idaho Stem Cells
- Illinois Stem Cells
- Indiana Stem Cells
- Iowa Stem Cells
- Kansas Stem Cells
- Kentucky Stem Cells
- Louisiana Stem Cells
- Maine Stem Cells
- Maryland Stem Cells
- Massachusetts Stem Cells
- Michigan Stem Cells
- Minnesota Stem Cells
- Mississippi Stem Cells
- Missouri Stem Cells
- Montana Stem Cells
- Nebraska Stem Cells
- New Hampshire Stem Cells
- New Jersey Stem Cells
- New Mexico Stem Cells
- New York Stem Cells
- Nevada Stem Cells
- North Carolina Stem Cells
- North Dakota Stem Cells
- Oklahoma Stem Cells
- Ohio Stem Cells
- Oregon Stem Cells
- Pennsylvania Stem Cells
- Rhode Island Stem Cells
- South Carolina Stem Cells
- South Dakota Stem Cells
- Tennessee Stem Cells
- Texas Stem Cells
- Utah Stem Cells
- Vermont Stem Cells
- Virginia Stem Cells
- Washington Stem Cells
- West Virginia Stem Cells
- Wisconsin Stem Cells
- Wyoming Stem Cells
- Biotechnology
- Cell Medicine
- Cell Therapy
- Diabetes
- Epigenetics
- Gene therapy
- Genetics
- Genetic Engineering
- Genetic medicine
- HCG Diet
- Hormone Replacement Therapy
- Human Genetics
- Integrative Medicine
- Molecular Genetics
- Molecular Medicine
- Nano medicine
- Preventative Medicine
- Regenerative Medicine
- Stem Cells
- Stell Cell Genetics
- Stem Cell Research
- Stem Cell Treatments
- Stem Cell Therapy
- Stem Cell Videos
- Testosterone Replacement Therapy
- Testosterone Shots
- Transhumanism
- Transhumanist
Archives
Recommended Sites
Category Archives: Global News Feed
Conduit Pharmaceuticals Inc. Announces Reverse Stock Split
Posted: May 19, 2025 at 2:44 am
NAPLES, Fla. and CAMBRIDGE, United Kingdom, May 16, 2025 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (“Conduit” or the “Company”), a dynamic, multi-asset clinical stage, life science company delivering an efficient model for compound development, announces that its board of directors has approved a 1-for-15 reverse stock split of the Company’s common stock. The Company’s stockholders approved the reverse stock split proposal at the Company’s Special Meeting of Stockholders held on May 5, 2025. They granted the board of directors the authority to determine the exact split ratio and when to proceed with the reverse stock split.
See more here:
Conduit Pharmaceuticals Inc. Announces Reverse Stock Split
Posted in Global News Feed
Comments Off on Conduit Pharmaceuticals Inc. Announces Reverse Stock Split
Mainz Biomed Announces Interim Read Out For Its eAArly DETECT 2 Clinical Study
Posted: May 19, 2025 at 2:44 am
Company intends to provide an interim read out by the end of summer 2025
Originally posted here:
Mainz Biomed Announces Interim Read Out For Its eAArly DETECT 2 Clinical Study
Posted in Global News Feed
Comments Off on Mainz Biomed Announces Interim Read Out For Its eAArly DETECT 2 Clinical Study
Medicines for Poland: Europe Faces a Critical Choice on Medicines and Market Reform
Posted: May 19, 2025 at 2:44 am
WARSAW, Poland, May 16, 2025 (GLOBE NEWSWIRE) -- Member States are nearing the end of discussions on EU pharmaceutical reform to ensure affordable medicines and support EU manufacturing in Europe. This will enhance the Union’s strategic resilience and autonomy, promote economic growth, and strengthen the sustainability of national healthcare systems.
See the original post here:
Medicines for Poland: Europe Faces a Critical Choice on Medicines and Market Reform
Posted in Global News Feed
Comments Off on Medicines for Poland: Europe Faces a Critical Choice on Medicines and Market Reform
Scilex Holding Company Presented Post-Hoc Analysis of the C.L.E.A.R. Trial on Clinical Meaningfulness of Safety and Efficacy of SP-102 for the…
Posted: May 19, 2025 at 2:44 am
PALO ALTO, Calif., May 16, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain and neurodegenerative and cardiometabolic disease, today presented the presentation of post-hoc analysis of the C.L.E.A.R. trial (Corticosteroid Lumbar Epidural Analgesia in Radiculopathy) interpreting clinical meaningfulness of safety and efficacy of SP-102 (SEMDEXA™) for the treatment of lumbosacral radicular pain (LRP) at the 27th Annual Meeting of American Society of Interventional Pain Physicians (ASIPP), May 15-17, 2025 in Orlando, FL.
Posted in Global News Feed
Comments Off on Scilex Holding Company Presented Post-Hoc Analysis of the C.L.E.A.R. Trial on Clinical Meaningfulness of Safety and Efficacy of SP-102 for the…
GRI Bio to Present at A.G.P.’s Annual Healthcare Company Showcase
Posted: May 19, 2025 at 2:44 am
Live webcast fireside chat with Marc Hertz, PhD, Chief Executive Officer on Wednesday, May 21st at 2:40 PM ET
Originally posted here:
GRI Bio to Present at A.G.P.'s Annual Healthcare Company Showcase
Posted in Global News Feed
Comments Off on GRI Bio to Present at A.G.P.’s Annual Healthcare Company Showcase
Transactions of Managers and Closely Associated Persons
Posted: May 19, 2025 at 2:44 am
Attached is a copy of a filing with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding transactions of managers and closely associated persons, announcing the acquisition of 19,988 shares in Alvotech at USD 10.18 per share, by Richard Davies, Deputy Chairman of the Board of Directors Alvotech. The transaction is dated May 14, 2025.
See the original post here:
Transactions of Managers and Closely Associated Persons
Posted in Global News Feed
Comments Off on Transactions of Managers and Closely Associated Persons
BlueSphere Bio Appoints Alan Korman, Ph.D. as Chief Scientific Officer
Posted: May 19, 2025 at 2:44 am
Seasoned executive brings more than three decades of immunotherapy and drug discovery experience Seasoned executive brings more than three decades of immunotherapy and drug discovery experience
Original post:
BlueSphere Bio Appoints Alan Korman, Ph.D. as Chief Scientific Officer
Posted in Global News Feed
Comments Off on BlueSphere Bio Appoints Alan Korman, Ph.D. as Chief Scientific Officer
TestoPrime Reviews Side Effects (INVESTIGATED) Is This Testosterone Booster Safe? (Ingredients, Results & Where to Buy)
Posted: May 19, 2025 at 2:44 am
MIAMI, May 16, 2025 (GLOBE NEWSWIRE) -- Natural male health supplements often attract attention for their bold claims—offering simple and effective ways to regain lost energy, stamina, and youthful vitality. For many men in their 40s and 50s, declining testosterone levels can lead to fatigue, reduced muscle mass, and diminished performance.
Posted in Global News Feed
Comments Off on TestoPrime Reviews Side Effects (INVESTIGATED) Is This Testosterone Booster Safe? (Ingredients, Results & Where to Buy)
